“I’m Not a Good Drug Dealer”: Styles of Buprenorphine Diversion in a Multisite Qualitative Study

Original research
par
McLean, Katherine & Philip R. Kavanaugh

Date de publication

2022

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

Little is known about the circumstances and motivations that surround buprenorphine diversion, particularly within the context of treatment expansion.

Constatations/points à retenir

Across our typology, market demand in the form of unmet need for buprenorphine was the major driver of diversion, suggesting that “supply-side interventions” intended to again limit access to BMT may be counterproductive.

La conception ou méthodologie de recherche

In-depth interviews (n=27)

Mots clés

Policy/Regulatory
Substitution/OAT
Diversion